-
Entity
-
Individual
-
Location
-
C/O Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B, Hayward, California
-
Summary
-
The estimated net worth of Peter A. Thompson is at least $274 M dollars as of June 24, 2024. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $228 M. Peter A. Thompson is the Director of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $30.3 M. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $14.5 M. Peter A. Thompson is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36 M.